The present invention relates to a process for preparing a solid oral dosage forms comprising effective amounts of fingolimod or salts thereof. In particular, the present invention relates to a process for preparing solid oral dosage forms comprising fingolimod or salts thereof, and other pharmaceutically acceptable excipients. The invention further relates to method of treating multiple sclerosis by using the composition fingolimod or salts thereof.